MedPath

Evaluation the effect of fenugreek on reducing blood lipids

Phase 3
Recruiting
Conditions
Hypercholesterolemia.
Registration Number
IRCT20210125050142N1
Lead Sponsor
ational institute for medical research development
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with low to moderate risk for cardiovascular events
LDL 116 -180 mg /d

Exclusion Criteria

Drinking alcohol,
Use of effective supplements on blood lipids (such as fish oil), Immunosuppressive drugs, blood lipid-lowering drugs (statins, fibrates, niacin, …)
People with hypothyroidism, nephrotic syndrome or renal dysfunction or liver dysfunction
People with uncontrolled hypertension (systolic blood pressure greater than 160 or diastolic blood pressure greater than 100 mmHg),
History of dizziness and convulsions,
Pregnancy or lactation
Sensitivity to studied plant

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean of Total Cholesterol. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of High-Density Lipoprotein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of Low-Density Lipoprotein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of Triglyceride. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of high-sensitivity C-reactive protein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.
Secondary Outcome Measures
NameTimeMethod
Mean of fasting blood sugar. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of blood pressure. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood pressure monitor.;Mean of body mass index. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Tape meters, digital scales and calculation formulas.
© Copyright 2025. All Rights Reserved by MedPath